HEADER HYDROLASE 25-DEC-06 2ODQ TITLE COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5- TITLE 2 CONVERTASE OF HUMAN COMPLEMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT C2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: COMPLEMENT C2A FRAGMENT; COMPND 5 SYNONYM: C3/C5 CONVERTASE; COMPND 6 EC: 3.4.21.43; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE(BTI-TN-5B1-4); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS COMPLEMENT COMPONENT C2A, C3/C5 CONVERTASE, COMPLEMENT SERINE KEYWDS 2 PROTEASE, HUMAN COMPLEMENT SYSTEM, GLYCOPROTEIN, SP, VWFA, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.V.L.NARAYANA,V.KRISHNAN REVDAT 7 25-OCT-23 2ODQ 1 REMARK REVDAT 6 10-NOV-21 2ODQ 1 SEQADV HETSYN REVDAT 5 29-JUL-20 2ODQ 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 13-JUL-11 2ODQ 1 VERSN REVDAT 3 24-FEB-09 2ODQ 1 VERSN REVDAT 2 13-MAR-07 2ODQ 1 JRNL REVDAT 1 06-FEB-07 2ODQ 0 JRNL AUTH V.KRISHNAN,Y.XU,K.MACON,J.E.VOLANAKIS,S.V.NARAYANA JRNL TITL THE CRYSTAL STRUCTURE OF C2A, THE CATALYTIC FRAGMENT OF JRNL TITL 2 CLASSICAL PATHWAY C3 AND C5 CONVERTASE OF HUMAN COMPLEMENT. JRNL REF J.MOL.BIOL. V. 367 224 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17234210 JRNL DOI 10.1016/J.JMB.2006.12.039 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 26457 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1397 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1914 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.3930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3883 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 112 REMARK 3 SOLVENT ATOMS : 134 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.77000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : -0.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.04000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.325 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.255 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.179 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.159 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4084 ; 0.027 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5533 ; 2.313 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 488 ; 7.182 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 188 ;34.857 ;24.415 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 701 ;18.073 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;22.514 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 632 ; 0.147 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3018 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1811 ; 0.235 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2701 ; 0.316 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 231 ; 0.183 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.286 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.364 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2534 ; 1.835 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3940 ; 2.347 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1766 ; 4.035 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1593 ; 5.625 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2ODQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041006. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27904 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1RRK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 10000, 0.1M HEPES, 0.3M GLYCYL REMARK 280 -GLYCYL-GLYCINE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.10050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 GLN A 469 REMARK 465 GLU A 470 REMARK 465 ARG A 490 REMARK 465 ASP A 491 REMARK 465 GLY A 492 REMARK 465 ASN A 493 REMARK 465 ASP A 494 REMARK 465 HIS A 495 REMARK 465 GLY A 687 REMARK 465 SER A 688 REMARK 465 ALA A 689 REMARK 465 ASP A 690 REMARK 465 LYS A 691 REMARK 465 PRO A 731 REMARK 465 LEU A 732 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 281 CG CD OE1 OE2 REMARK 470 LEU A 336 CG CD1 CD2 REMARK 470 LYS A 395 CB CG CD CE NZ REMARK 470 SER A 496 OG REMARK 470 LEU A 497 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 589 O HOH A 82 2.15 REMARK 500 O HOH A 36 O HOH A 91 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 402 NH2 ARG A 699 2545 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 402 CB GLU A 402 CG 0.121 REMARK 500 GLU A 402 CD GLU A 402 OE2 0.083 REMARK 500 VAL A 435 CB VAL A 435 CG1 -0.133 REMARK 500 GLN A 576 C GLN A 576 O 0.116 REMARK 500 VAL A 674 CB VAL A 674 CG2 0.129 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 240 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 PRO A 282 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 LYS A 381 CD - CE - NZ ANGL. DEV. = 14.1 DEGREES REMARK 500 PRO A 466 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 ASP A 479 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP A 634 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG A 668 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 706 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG A 706 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG A 714 CG - CD - NE ANGL. DEV. = -13.0 DEGREES REMARK 500 ARG A 714 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 714 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 MET A 715 CG - SD - CE ANGL. DEV. = -10.8 DEGREES REMARK 500 ARG A 720 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG A 720 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 279 -102.07 -141.10 REMARK 500 MET A 339 0.25 -64.19 REMARK 500 LYS A 358 60.10 -104.55 REMARK 500 ASN A 360 10.50 -143.26 REMARK 500 LEU A 396 153.70 -29.73 REMARK 500 ASP A 399 94.97 -68.14 REMARK 500 GLN A 480 -12.93 -140.74 REMARK 500 GLN A 508 -9.04 -56.83 REMARK 500 ASP A 525 101.94 -168.98 REMARK 500 VAL A 635 -38.94 -32.75 REMARK 500 GLN A 649 -124.62 50.72 REMARK 500 SER A 678 -65.56 -122.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 643 LEU A 644 147.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: OLIGOSACCHARIDE INHIBITOR REMARK 630 MOLECULE NAME: 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 NAG A 807 REMARK 630 NAG A 808 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: NULL REMARK 630 DETAILS: OLIGOSACCHARIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ODP RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH MG ION DBREF 2ODQ A 224 732 UNP P06681 CO2_HUMAN 244 752 SEQADV 2ODQ ALA A 241 UNP P06681 CYS 261 ENGINEERED MUTATION SEQRES 1 A 509 LYS ILE GLN ILE GLN ARG SER GLY HIS LEU ASN LEU TYR SEQRES 2 A 509 LEU LEU LEU ASP ALA SER GLN SER VAL SER GLU ASN ASP SEQRES 3 A 509 PHE LEU ILE PHE LYS GLU SER ALA SER LEU MET VAL ASP SEQRES 4 A 509 ARG ILE PHE SER PHE GLU ILE ASN VAL SER VAL ALA ILE SEQRES 5 A 509 ILE THR PHE ALA SER GLU PRO LYS VAL LEU MET SER VAL SEQRES 6 A 509 LEU ASN ASP ASN SER ARG ASP MET THR GLU VAL ILE SER SEQRES 7 A 509 SER LEU GLU ASN ALA ASN TYR LYS ASP HIS GLU ASN GLY SEQRES 8 A 509 THR GLY THR ASN THR TYR ALA ALA LEU ASN SER VAL TYR SEQRES 9 A 509 LEU MET MET ASN ASN GLN MET ARG LEU LEU GLY MET GLU SEQRES 10 A 509 THR MET ALA TRP GLN GLU ILE ARG HIS ALA ILE ILE LEU SEQRES 11 A 509 LEU THR ASP GLY LYS SER ASN MET GLY GLY SER PRO LYS SEQRES 12 A 509 THR ALA VAL ASP HIS ILE ARG GLU ILE LEU ASN ILE ASN SEQRES 13 A 509 GLN LYS ARG ASN ASP TYR LEU ASP ILE TYR ALA ILE GLY SEQRES 14 A 509 VAL GLY LYS LEU ASP VAL ASP TRP ARG GLU LEU ASN GLU SEQRES 15 A 509 LEU GLY SER LYS LYS ASP GLY GLU ARG HIS ALA PHE ILE SEQRES 16 A 509 LEU GLN ASP THR LYS ALA LEU HIS GLN VAL PHE GLU HIS SEQRES 17 A 509 MET LEU ASP VAL SER LYS LEU THR ASP THR ILE CYS GLY SEQRES 18 A 509 VAL GLY ASN MET SER ALA ASN ALA SER ASP GLN GLU ARG SEQRES 19 A 509 THR PRO TRP HIS VAL THR ILE LYS PRO LYS SER GLN GLU SEQRES 20 A 509 THR CYS ARG GLY ALA LEU ILE SER ASP GLN TRP VAL LEU SEQRES 21 A 509 THR ALA ALA HIS CYS PHE ARG ASP GLY ASN ASP HIS SER SEQRES 22 A 509 LEU TRP ARG VAL ASN VAL GLY ASP PRO LYS SER GLN TRP SEQRES 23 A 509 GLY LYS GLU PHE LEU ILE GLU LYS ALA VAL ILE SER PRO SEQRES 24 A 509 GLY PHE ASP VAL PHE ALA LYS LYS ASN GLN GLY ILE LEU SEQRES 25 A 509 GLU PHE TYR GLY ASP ASP ILE ALA LEU LEU LYS LEU ALA SEQRES 26 A 509 GLN LYS VAL LYS MET SER THR HIS ALA ARG PRO ILE CYS SEQRES 27 A 509 LEU PRO CYS THR MET GLU ALA ASN LEU ALA LEU ARG ARG SEQRES 28 A 509 PRO GLN GLY SER THR CYS ARG ASP HIS GLU ASN GLU LEU SEQRES 29 A 509 LEU ASN LYS GLN SER VAL PRO ALA HIS PHE VAL ALA LEU SEQRES 30 A 509 ASN GLY SER LYS LEU ASN ILE ASN LEU LYS MET GLY VAL SEQRES 31 A 509 GLU TRP THR SER CYS ALA GLU VAL VAL SER GLN GLU LYS SEQRES 32 A 509 THR MET PHE PRO ASN LEU THR ASP VAL ARG GLU VAL VAL SEQRES 33 A 509 THR ASP GLN PHE LEU CYS SER GLY THR GLN GLU ASP GLU SEQRES 34 A 509 SER PRO CYS LYS GLY GLU SER GLY GLY ALA VAL PHE LEU SEQRES 35 A 509 GLU ARG ARG PHE ARG PHE PHE GLN VAL GLY LEU VAL SER SEQRES 36 A 509 TRP GLY LEU TYR ASN PRO CYS LEU GLY SER ALA ASP LYS SEQRES 37 A 509 ASN SER ARG LYS ARG ALA PRO ARG SER LYS VAL PRO PRO SEQRES 38 A 509 PRO ARG ASP PHE HIS ILE ASN LEU PHE ARG MET GLN PRO SEQRES 39 A 509 TRP LEU ARG GLN HIS LEU GLY ASP VAL LEU ASN PHE LEU SEQRES 40 A 509 PRO LEU MODRES 2ODQ ASN A 631 ASN GLYCOSYLATION SITE MODRES 2ODQ ASN A 447 ASN GLYCOSYLATION SITE MODRES 2ODQ ASN A 601 ASN GLYCOSYLATION SITE MODRES 2ODQ ASN A 313 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG B 3 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG C 3 14 HET NAG A 807 14 HET NAG A 808 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 8(C8 H15 N O6) FORMUL 6 HOH *134(H2 O) HELIX 1 1 SER A 246 PHE A 265 1 20 HELIX 2 2 SER A 266 GLU A 268 5 3 HELIX 3 3 ASN A 290 ARG A 294 5 5 HELIX 4 4 ASP A 295 ASN A 305 1 11 HELIX 5 5 ASN A 307 GLU A 312 5 6 HELIX 6 6 ASN A 318 GLY A 338 1 21 HELIX 7 7 THR A 341 GLU A 346 1 6 HELIX 8 8 PRO A 365 LEU A 376 1 12 HELIX 9 9 ASN A 379 ASP A 384 5 6 HELIX 10 10 ASP A 399 GLY A 407 1 9 HELIX 11 11 ASP A 421 MET A 432 1 12 HELIX 12 12 SER A 453 THR A 458 1 6 HELIX 13 13 ALA A 485 PHE A 489 5 5 HELIX 14 14 LYS A 529 GLY A 533 5 5 HELIX 15 15 THR A 565 LEU A 572 1 8 HELIX 16 16 THR A 579 LEU A 588 1 10 HELIX 17 17 GLY A 612 VAL A 621 1 10 HELIX 18 18 VAL A 622 GLU A 625 5 4 HELIX 19 19 ASP A 634 VAL A 638 5 5 HELIX 20 20 CYS A 655 SER A 659 5 5 HELIX 21 21 MET A 715 GLY A 724 1 10 SHEET 1 A 2 ILE A 225 GLN A 226 0 SHEET 2 A 2 LEU A 433 ASP A 434 1 O ASP A 434 N ILE A 225 SHEET 1 B 6 PRO A 282 MET A 286 0 SHEET 2 B 6 VAL A 271 PHE A 278 -1 N THR A 277 O LYS A 283 SHEET 3 B 6 HIS A 232 ASP A 240 1 N LEU A 235 O SER A 272 SHEET 4 B 6 ILE A 347 LEU A 354 1 O ILE A 352 N LEU A 238 SHEET 5 B 6 LEU A 386 VAL A 393 1 O TYR A 389 N ILE A 351 SHEET 6 B 6 ALA A 416 LEU A 419 1 O LEU A 419 N GLY A 392 SHEET 1 C 7 LYS A 511 PHE A 513 0 SHEET 2 C 7 ARG A 499 VAL A 502 -1 N VAL A 502 O LYS A 511 SHEET 3 C 7 HIS A 461 LYS A 465 -1 N THR A 463 O ASN A 501 SHEET 4 C 7 CYS A 472 LEU A 476 -1 O CYS A 472 N ILE A 464 SHEET 5 C 7 TRP A 481 THR A 484 -1 O LEU A 483 N ALA A 475 SHEET 6 C 7 ALA A 543 LEU A 547 -1 O ALA A 543 N THR A 484 SHEET 7 C 7 ILE A 515 ILE A 520 -1 N GLU A 516 O LYS A 546 SHEET 1 D 2 SER A 592 VAL A 598 0 SHEET 2 D 2 LYS A 604 LYS A 610 -1 O ILE A 607 N ALA A 595 SHEET 1 E 4 PHE A 643 SER A 646 0 SHEET 2 E 4 ASP A 707 ASN A 711 -1 O ASP A 707 N SER A 646 SHEET 3 E 4 ARG A 670 GLY A 680 -1 N TRP A 679 O PHE A 708 SHEET 4 E 4 ALA A 662 ARG A 667 -1 N LEU A 665 O PHE A 672 SSBOND 1 CYS A 443 CYS A 561 1555 1555 2.10 SSBOND 2 CYS A 472 CYS A 488 1555 1555 1.96 SSBOND 3 CYS A 564 CYS A 580 1555 1555 2.01 SSBOND 4 CYS A 618 CYS A 645 1555 1555 2.08 SSBOND 5 CYS A 655 CYS A 685 1555 1555 2.04 LINK ND2 ASN A 313 C1 NAG A 808 1555 1555 1.47 LINK ND2 ASN A 447 C1 NAG C 1 1555 1555 1.48 LINK ND2 ASN A 601 C1 NAG A 807 1555 1555 1.39 LINK ND2 ASN A 631 C1 NAG B 1 1555 1555 2.13 LINK O3 NAG B 1 C1 NAG B 2 1555 1555 1.48 LINK O4 NAG B 1 C1 NAG B 3 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.42 LINK O4 NAG C 2 C1 NAG C 3 1555 1555 1.50 CISPEP 1 VAL A 702 PRO A 703 0 8.77 CRYST1 51.354 84.201 74.426 90.00 92.10 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019473 0.000000 0.000713 0.00000 SCALE2 0.000000 0.011876 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013445 0.00000